<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:51:59 -0700</creation_date>
  <update_date>2013-05-27 11:05:33 -0600</update_date>
  <accession>HMDBP00843</accession>
  <secondary_accessions>
    <accession>6124</accession>
    <accession>HMDBP06536</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>Acid beta-galactosidase</synonym>
    <synonym>Elastin receptor 1</synonym>
    <synonym>Lactase</synonym>
  </synonyms>
  <gene_name>GLB1</gene_name>
  <general_function>Involved in hydrolase activity, hydrolyzing O-glycosyl compounds</general_function>
  <specific_function>Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.
Isoform 2 has no beta-galactosidase catalytic activity, but plays functional roles in the formation of extracellular elastic fibers (elastogenesis) and in the development of connective tissue. Seems to be identical to the elastin-binding protein (EBP), a major component of the non-integrin cell surface receptor expressed on fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. In elastin producing cells, associates with tropoelastin intracellularly and functions as a recycling molecular chaperone which facilitates the secretions of tropoelastin and its assembly into elastic fibers.
</specific_function>
  <pathways>
    <pathway>
      <name>Galactose metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00052</kegg_map_id>
    </pathway>
    <pathway>
      <name>Other glycan degradation</name>
      <smpdb_id/>
      <kegg_map_id>map00511</kegg_map_id>
    </pathway>
    <pathway>
      <name>Glycosaminoglycan degradation</name>
      <smpdb_id/>
      <kegg_map_id>map00531</kegg_map_id>
    </pathway>
    <pathway>
      <name>sphingolipid metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00600</kegg_map_id>
    </pathway>
    <pathway>
      <name>Glycosphingolipid biosynthesis - ganglio series</name>
      <smpdb_id/>
      <kegg_map_id>map00604</kegg_map_id>
    </pathway>
    <pathway>
      <name>Lysosome</name>
      <smpdb_id/>
      <kegg_map_id>map04142</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00186</accession>
      <name>Alpha-Lactose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00143</accession>
      <name>D-Galactose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00131</accession>
      <name>Glycerol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06750</accession>
      <name>Lactosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00140</accession>
      <name>Glucosylceramide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00516</accession>
      <name>Beta-D-Glucose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01030</accession>
      <name>3'-Ketolactose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01385</accession>
      <name>3-Keto-b-D-galactose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01429</accession>
      <name>Phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03345</accession>
      <name>Alpha-D-Glucose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04162</accession>
      <name>Galactan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04853</accession>
      <name>Ganglioside GM1 (18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04854</accession>
      <name>Ganglioside GM1 (18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04855</accession>
      <name>Ganglioside GM1 (18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04856</accession>
      <name>Ganglioside GM1 (18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04857</accession>
      <name>Ganglioside GM1 (18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04858</accession>
      <name>Ganglioside GM1 (18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04859</accession>
      <name>Ganglioside GM1 (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04860</accession>
      <name>Ganglioside GM1 (d18:1/26:1(17Z)))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04861</accession>
      <name>Ganglioside GM1 (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04863</accession>
      <name>Ganglioside GM1 (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04865</accession>
      <name>Ganglioside GM1 (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04866</accession>
      <name>Lactosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04872</accession>
      <name>Lactosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04873</accession>
      <name>Lactosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04874</accession>
      <name>Lactosylceramide (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04876</accession>
      <name>Lactosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04888</accession>
      <name>Ganglioside GA2 (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04889</accession>
      <name>Ganglioside GA2 (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04890</accession>
      <name>Ganglioside GA2 (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04891</accession>
      <name>Ganglioside GA2 (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04892</accession>
      <name>Ganglioside GA2 (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04893</accession>
      <name>Ganglioside GA2 (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04894</accession>
      <name>Ganglioside GA2 (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04895</accession>
      <name>Ganglioside GA2 (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04896</accession>
      <name>Ganglioside GA2 (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04897</accession>
      <name>Ganglioside GA2 (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04898</accession>
      <name>Ganglioside GA2 (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04900</accession>
      <name>Ganglioside GA1 (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04901</accession>
      <name>Ganglioside GA1 (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04902</accession>
      <name>Ganglioside GA1 (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04903</accession>
      <name>Ganglioside GA1 (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04904</accession>
      <name>Ganglioside GA1 (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04905</accession>
      <name>Ganglioside GA1 (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04906</accession>
      <name>Ganglioside GA1 (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04907</accession>
      <name>Ganglioside GA1 (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04908</accession>
      <name>Ganglioside GA1 (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04909</accession>
      <name>Ganglioside GA1 (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04910</accession>
      <name>Ganglioside GA1 (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04936</accession>
      <name>Ganglioside GM2 (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04937</accession>
      <name>Ganglioside GM2 (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04938</accession>
      <name>Ganglioside GM2 (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04939</accession>
      <name>Ganglioside GM2 (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04941</accession>
      <name>Ganglioside GM2 (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04942</accession>
      <name>Ganglioside GM2 (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04943</accession>
      <name>Ganglioside GM2 (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04944</accession>
      <name>Ganglioside GM2 (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04945</accession>
      <name>Ganglioside GM2 (d18:1/24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04946</accession>
      <name>Ganglioside GM2 (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04969</accession>
      <name>Glucosylceramide (d18:1/12:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04970</accession>
      <name>Glucosylceramide (d18:1/9Z-18:1)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04971</accession>
      <name>Glucosylceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04972</accession>
      <name>Glucosylceramide (d18:1/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04973</accession>
      <name>Glucosylceramide (d18:1/20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04974</accession>
      <name>Glucosylceramide (d18:1/22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04975</accession>
      <name>Glucosylceramide (d18:1/24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04976</accession>
      <name>Glucosylceramide (d18:1/26:1(17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04977</accession>
      <name>Glucosylceramide (d18:1/26:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04979</accession>
      <name>Glucosylceramide (d18:1/25:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06789</accession>
      <name>Lactose 6-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03449</accession>
      <name>Beta-D-Galactose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06790</accession>
      <name>Galactosylglycerol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41627</accession>
      <name>beta-Lactose</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>ion binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>cation binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on glycosyl bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, hydrolyzing o-glycosyl compounds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>primary metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>carbohydrate metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>lysosomal lumen</description>
      <go_id>GO:0043202</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>perinuclear region of cytoplasm</description>
      <go_id>GO:0048471</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>beta-galactosidase activity</description>
      <go_id>GO:0004565</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>cation binding</description>
      <go_id>GO:0043169</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>galactoside binding</description>
      <go_id>GO:0016936</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>carbohydrate metabolic process</description>
      <go_id>GO:0005975</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>galactose catabolic process</description>
      <go_id>GO:0019388</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>glycosphingolipid metabolic process</description>
      <go_id>GO:0006687</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>keratan sulfate catabolic process</description>
      <go_id>GO:0042340</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>phospholipid metabolic process</description>
      <go_id>GO:0006644</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Isoform 2:Cytoplasm</subcellular_location>
    <subcellular_location>perinuclear region</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location></chromosome_location>
    <locus></locus>
    <gene_sequence>&gt;2034 bp
ATGCCGGGGTTCCTGGTTCGCATCCTCCCTCTGTTGCTGGTTCTGCTGCTTCTGGGCCCT
ACGCGCGGCTTGCGCAATGCCACCCAGAGGATGTTTGAAATTGACTATAGCCGGGACTCC
TTCCTCAAGGATGGCCAGCCATTTCGCTACATCTCAGGAAGCATTCACTACTCCCGTGTG
CCCCGCTTCTACTGGAAGGACCGGCTGCTGAAGATGAAGATGGCTGGGCTGAACGCCATC
CAGACGTATGTGCCCTGGAACTTTCATGAGCCCTGGCCAGGACAGTACCAGTTTTCTGAG
GACCATGATGTGGAATATTTTCTTCGGCTGGCTCATGAGCTGGGACTGCTGGTTATCCTG
AGGCCCGGGCCCTACATCTGTGCAGAGTGGGAAATGGGAGGATTACCTGCTTGGCTGCTA
GAGAAAGAGTCTATTCTTCTCCGCTCCTCCGACCCAGATTACCTGGCAGCTGTGGACAAG
TGGTTGGGAGTCCTTCTGCCCAAGATGAAGCCTCTCCTCTATCAGAATGGAGGGCCAGTT
ATAACAGTGCAGGTTGAAAATGAATATGGCAGCTACTTTGCCTGTGATTTTGACTACCTC
GCGTTCCTGCAGAAGCGCTTTCGCCACCATCTGGGGGATGATGTGGTTCTGTTTACCACT
GATGGAGCACATAAAACATTCCTGAAATGTGGGGCCCTGCAGGGCCTCTACACCACGGTG
GACTTTGGAACAGGCAGCAACATCACAGATGCTTTCCTAAGCCAGAGGAAGTGTGAGCCC
AAAGGACCCTTGATCAATTCTGAATTCTATACTGGCTGGCTAGATCACTGGGGCCAACCT
CACTCCACAATCAAGACCGAAGCAGTGGCTTCCTCCCTCTATGATATACTTGCCCGTGGG
GCGAGTGTGAACTTGTACATGTTTATAGGTGGGACCAATTTTGCCTATTGGAATGGGGCC
AACTCACCCTATGCAGCACAGCCCACCAGCTACGACTATGATGCCCCACTGAGTGAGGCT
GGGGACCTCACTGAGAAGTATTTTGCTCTGCGAAACATCATCCAGAAGTTTGAAAAAGTA
CCAGAAGGTCCTATCCCTCCATCTACACCAAAGTTTGCATATGGAAAGGTCACTTTGGAA
AAGTTAAAGACAGTGGGAGCAGCTCTGGACATTCTGTGTCCCTCTGGGCCCATCAAAAGC
CTTTATCCCTTGACATTTATCCAGGTGAAACAGCATTATGGGTTTGTGCTGTACCGGACA
ACACTTCCTCAAGATTGCAGCAACCCAGCACCTCTCTCTTCACCCCTCAATGGAGTCCAC
GATCGAGCATATGTTGCTGTGGATGGGATCCCCCAGGGAGTCCTTGAGCGAAACAATGTG
ATCACTCTGAACATAACAGGGAAAGCTGGAGCCACTCTGGACCTTCTGGTAGAGAACATG
GGACGTGTGAACTATGGTGCATATATCAACGATTTTAAGGGTTTGGTTTCTAACCTGACT
CTCAGTTCCAATATCCTCACGGACTGGACGATCTTTCCACTGGACACTGAGGATGCAGTG
CGCAGCCACCTGGGGGGCTGGGGACACCGTGACAGTGGCCACCATGATGAAGCCTGGGCC
CACAACTCATCCAACTACACGCTCCCGGCCTTTTATATGGGGAACTTCTCCATTCCCAGT
GGGATCCCAGACTTGCCCCAGGACACCTTTATCCAGTTTCCTGGATGGACCAAGGGCCAG
GTCTGGATTAATGGCTTTAACCTTGGCCGCTATTGGCCAGCCCGGGGCCCTCAGTTGACC
TTGTTTGTGCCCCAGCACATCCTGATGACCTCGGCCCCAAACACCATCACCGTGCTGGAA
CTGGAGTGGGCACCCTGCAGCAGTGATGATCCAGAACTATGTGCTGTGACGTTCGTGGAC
AGGCCAGTTATTGGCTCATCTGTGACCTACGATCATCCCTCCAAACCTGTTGAAAAAAGA
CTCATGCCCCCACCCCCGCAAAAAAACAAAGATTCATGGCTGGACCATGTATGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>677</residue_number>
    <molecular_weight/>
    <theoretical_pi/>
    <pfams>
      <pfam>
        <name>Glyco_hydro_35</name>
        <pfam_id>PF01301</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Beta-galactosidase
MPGFLVRILPLLLVLLLLGPTRGLRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRV
PRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVIL
RPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPV
ITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTV
DFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARG
ASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKV
PEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRT
TLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENM
GRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWA
HNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLT
LFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKR
LMPPPPQKNKDSWLDHV</protein_sequence>
  </protein_properties>
  <genbank_protein_id>179419</genbank_protein_id>
  <uniprot_id>P16278</uniprot_id>
  <uniprot_name>BGAL_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>3THC</pdb_id>
    <pdb_id>3THD</pdb_id>
  </pdb_ids>
  <genbank_gene_id>M22590</genbank_gene_id>
  <genecard_id>GLB1</genecard_id>
  <geneatlas_id>GLB1</geneatlas_id>
  <hgnc_id>HGNC:4298</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Oshima A, Tsuji A, Nagao Y, Sakuraba H, Suzuki Y: Cloning, sequencing, and expression of cDNA for human beta-galactosidase.  Biochem Biophys Res Commun. 1988 Nov 30;157(1):238-44.</reference_text>
      <pubmed_id>3143362</pubmed_id>
    </reference>
    <reference>
      <reference_text>Morreau H, Galjart NJ, Gillemans N, Willemsen R, van der Horst GT, d'Azzo A: Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J Biol Chem. 1989 Dec 5;264(34):20655-63.</reference_text>
      <pubmed_id>2511208</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yamamoto Y, Hake CA, Martin BM, Kretz KA, Ahern-Rindell AJ, Naylor SL, Mudd M, O'Brien JS: Isolation, characterization, and mapping of a human acid beta-galactosidase cDNA. DNA Cell Biol. 1990 Mar;9(2):119-27.</reference_text>
      <pubmed_id>2111707</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Muzny DM, Scherer SE, Kaul R, Wang J, Yu J, Sudbrak R, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Wei S, Wheeler DA, Wright MW, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clendenning J, Clerc-Blankenburg KP, Chen R, Chen Z, Davis C, Delgado O, Dinh HH, Dong W, Draper H, Ernst S, Fu G, Gonzalez-Garay ML, Garcia DK, Gillett W, Gu J, Hao B, Haugen E, Havlak P, He X, Hennig S, Hu S, Huang W, Jackson LR, Jacob LS, Kelly SH, Kube M, Levy R, Li Z, Liu B, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Palmeiri A, Pasternak S, Perez LM, Phelps KA, Plopper FJ, Qiang B, Raymond C, Rodriguez R, Saenphimmachak C, Santibanez J, Shen H, Shen Y, Subramanian S, Tabor PE, Verduzco D, Waldron L, Wang J, Wang J, Wang Q, Williams GA, Wong GK, Yao Z, Zhang J, Zhang X, Zhao G, Zhou J, Zhou Y, Nelson D, Lehrach H, Reinhardt R, Naylor SL, Yang H, Olson M, Weinstock G, Gibbs RA: The DNA sequence, annotation and analysis of human chromosome 3.  Nature. 2006 Apr 27;440(7088):1194-8.</reference_text>
      <pubmed_id>16641997</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hinek A, Rabinovitch M, Keeley F, Okamura-Oho Y, Callahan J: The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest. 1993 Mar;91(3):1198-205.</reference_text>
      <pubmed_id>8383699</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hinek A: Biological roles of the non-integrin elastin/laminin receptor.  Biol Chem. 1996 Jul-Aug;377(7-8):471-80.</reference_text>
      <pubmed_id>8922281</pubmed_id>
    </reference>
    <reference>
      <reference_text>Privitera S, Prody CA, Callahan JW, Hinek A: The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem. 1998 Mar 13;273(11):6319-26.</reference_text>
      <pubmed_id>9497360</pubmed_id>
    </reference>
    <reference>
      <reference_text>Callahan JW: Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Biochim Biophys Acta. 1999 Oct 8;1455(2-3):85-103.</reference_text>
      <pubmed_id>10571006</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hinek A, Zhang S, Smith AC, Callahan JW: Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase. Am J Hum Genet. 2000 Jul;67(1):23-36. Epub 2000 Jun 6.</reference_text>
      <pubmed_id>10841810</pubmed_id>
    </reference>
    <reference>
      <reference_text>Lewandrowski U, Moebius J, Walter U, Sickmann A: Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics. 2006 Feb;5(2):226-33. Epub 2005 Oct 31.</reference_text>
      <pubmed_id>16263699</pubmed_id>
    </reference>
    <reference>
      <reference_text>Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.</reference_text>
      <pubmed_id>19159218</pubmed_id>
    </reference>
    <reference>
      <reference_text>Oshima A, Yoshida K, Shimmoto M, Fukuhara Y, Sakuraba H, Suzuki Y: Human beta-galactosidase gene mutations in morquio B disease.  Am J Hum Genet. 1991 Nov;49(5):1091-3.</reference_text>
      <pubmed_id>1928092</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nishimoto J, Nanba E, Inui K, Okada S, Suzuki K: GM1-gangliosidosis (genetic beta-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients. Am J Hum Genet. 1991 Sep;49(3):566-74.</reference_text>
      <pubmed_id>1909089</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yoshida K, Oshima A, Shimmoto M, Fukuhara Y, Sakuraba H, Yanagisawa N, Suzuki Y: Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases. Am J Hum Genet. 1991 Aug;49(2):435-42.</reference_text>
      <pubmed_id>1907800</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mosna G, Fattore S, Tubiello G, Brocca S, Trubia M, Gianazza E, Gatti R, Danesino C, Minelli A, Piantanida M: A homozygous missense arginine to histidine substitution at position 482 of the beta-galactosidase in an Italian infantile GM1-gangliosidosis patient. Hum Genet. 1992 Nov;90(3):247-50.</reference_text>
      <pubmed_id>1487238</pubmed_id>
    </reference>
    <reference>
      <reference_text>Boustany RM, Qian WH, Suzuki K: Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients. Am J Hum Genet. 1993 Oct;53(4):881-8.</reference_text>
      <pubmed_id>8213816</pubmed_id>
    </reference>
    <reference>
      <reference_text>Chakraborty S, Rafi MA, Wenger DA: Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis. Am J Hum Genet. 1994 Jun;54(6):1004-13.</reference_text>
      <pubmed_id>8198123</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ishii N, Oohira T, Oshima A, Sakuraba H, Endo F, Matsuda I, Sukegawa K, Orii T, Suzuki Y: Clinical and molecular analysis of a Japanese boy with Morquio B disease.  Clin Genet. 1995 Aug;48(2):103-8.</reference_text>
      <pubmed_id>7586649</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kaye EM, Shalish C, Livermore J, Taylor HA, Stevenson RE, Breakefield XO: beta-Galactosidase gene mutations in patients with slowly progressive GM1 gangliosidosis. J Child Neurol. 1997 Jun;12(4):242-7.</reference_text>
      <pubmed_id>9203065</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bagshaw RD, Zhang S, Hinek A, Skomorowski MA, Whelan D, Clarke JT, Callahan JW: Novel mutations (Asn 484 Lys, Thr 500 Ala, Gly 438 Glu) in Morquio B disease. Biochim Biophys Acta. 2002 Dec 12;1588(3):247-53.</reference_text>
      <pubmed_id>12393180</pubmed_id>
    </reference>
    <reference>
      <reference_text>Silva CM, Severini MH, Sopelsa A, Coelho JC, Zaha A, d'Azzo A, Giugliani R: Six novel beta-galactosidase gene mutations in Brazilian patients with GM1-gangliosidosis. Hum Mutat. 1999;13(5):401-9.</reference_text>
      <pubmed_id>10338095</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhang S, Bagshaw R, Hilson W, Oho Y, Hinek A, Clarke JT, Callahan JW: Characterization of beta-galactosidase mutations Asp332--&amp;gt;Asn and Arg148--&amp;gt;Ser, and a polymorphism, Ser532--&amp;gt;Gly, in a case of GM1 gangliosidosis. Biochem J. 2000 Jun 15;348 Pt 3:621-32.</reference_text>
      <pubmed_id>10839995</pubmed_id>
    </reference>
    <reference>
      <reference_text>Morrone A, Bardelli T, Donati MA, Giorgi M, Di Rocco M, Gatti R, Parini R, Ricci R, Taddeucci G, D'Azzo A, Zammarchi E: beta-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. Hum Mutat. 2000;15(4):354-66.</reference_text>
      <pubmed_id>10737981</pubmed_id>
    </reference>
    <reference>
      <reference_text>Paschke E, Milos I, Kreimer-Erlacher H, Hoefler G, Beck M, Hoeltzenbein M, Kleijer W, Levade T, Michelakakis H, Radeva B: Mutation analyses in 17 patients with deficiency in acid beta-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B. Hum Genet. 2001 Aug;109(2):159-66.</reference_text>
      <pubmed_id>11511921</pubmed_id>
    </reference>
    <reference>
      <reference_text>Caciotti A, Bardelli T, Cunningham J, D'Azzo A, Zammarchi E, Morrone A: Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient. Hum Genet. 2003 Jul;113(1):44-50. Epub 2003 Mar 19.</reference_text>
      <pubmed_id>12644936</pubmed_id>
    </reference>
    <reference>
      <reference_text>Georgiou T, Drousiotou A, Campos Y, Caciotti A, Sztriha L, Gururaj A, Ozand P, Zammarchi E, Morrone A, D'Azzo A: Four novel mutations in patients from the Middle East with the infantile form of GM1-gangliosidosis. Hum Mutat. 2004 Oct;24(4):352.</reference_text>
      <pubmed_id>15365997</pubmed_id>
    </reference>
    <reference>
      <reference_text>Caciotti A, Donati MA, Boneh A, d'Azzo A, Federico A, Parini R, Antuzzi D, Bardelli T, Nosi D, Kimonis V, Zammarchi E, Morrone A: Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis. Hum Mutat. 2005 Mar;25(3):285-92.</reference_text>
      <pubmed_id>15714521</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gururaj A, Sztriha L, Hertecant J, Johansen JG, Georgiou T, Campos Y, Drousiotou A, d'Azzo A: Magnetic resonance imaging findings and novel mutations in GM1 gangliosidosis. J Child Neurol. 2005 Jan;20(1):57-60.</reference_text>
      <pubmed_id>15791924</pubmed_id>
    </reference>
    <reference>
      <reference_text>Roze E, Paschke E, Lopez N, Eck T, Yoshida K, Maurel-Ollivier A, Doummar D, Caillaud C, Galanaud D, Billette de Villemeur T, Vidailhet M, Roubergue A: Dystonia and parkinsonism in GM1 type 3 gangliosidosis.  Mov Disord. 2005 Oct;20(10):1366-9.</reference_text>
      <pubmed_id>15986423</pubmed_id>
    </reference>
    <reference>
      <reference_text>Santamaria R, Chabas A, Coll MJ, Miranda CS, Vilageliu L, Grinberg D: Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies. Hum Mutat. 2006 Oct;27(10):1060.</reference_text>
      <pubmed_id>16941474</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tatano Y, Takeuchi N, Kuwahara J, Sakuraba H, Takahashi T, Takada G, Itoh K: Elastogenesis in cultured dermal fibroblasts from patients with lysosomal beta-galactosidase, protective protein/cathepsin A and neuraminidase-1 deficiencies. J Med Invest. 2006 Feb;53(1-2):103-12.</reference_text>
      <pubmed_id>16538002</pubmed_id>
    </reference>
    <reference>
      <reference_text>Santamaria R, Blanco M, Chabas A, Grinberg D, Vilageliu L: Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America. Clin Genet. 2007 Mar;71(3):273-9.</reference_text>
      <pubmed_id>17309651</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gort L, Santamaria R, Grinberg D, Vilageliu L, Chabas A: Identification of a novel pseudodeficiency allele in the GLB1 gene in a carrier of GM1 gangliosidosis. Clin Genet. 2007 Aug;72(2):109-11.</reference_text>
      <pubmed_id>17661814</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hofer D, Paul K, Fantur K, Beck M, Burger F, Caillaud C, Fumic K, Ledvinova J, Lugowska A, Michelakakis H, Radeva B, Ramaswami U, Plecko B, Paschke E: GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase. Hum Mutat. 2009 Aug;30(8):1214-21.</reference_text>
      <pubmed_id>19472408</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
  </metabolite_references>
</protein>
